{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:03:32Z","timestamp":1792537412143,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007224","name":"National Foundation for Science and Technology Development","doi-asserted-by":"publisher","award":["239\/Q\u0110-H\u0110QL-NAFOSTED"],"award-info":[{"award-number":["239\/Q\u0110-H\u0110QL-NAFOSTED"]}],"id":[{"id":"10.13039\/100007224","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Despite noticeable improvement in anti-malarial treatment, rapid growth of resistant malaria strains points out the need for continuous development of novel anti-malarials to fight the disastrous infection. Haemozoin is considered as a novel inhibitory pathway for new anti-malarial drugs, therefore, this study aimed to systematically review all articles investigating the correlation between anti-malarial and anti-haemozoin activities of anti-malarial compounds.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A literature search was conducted on 22 October 2017 in eight databases for relevant in vitro articles reporting the correlation between anti-malarial and anti-haemozoin of anti-malarial compounds, based on the constructed search terms and inclusion criteria. ToxRtool was used to assess quality of each study.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>A total of ten articles were included in the review. In vitro anti-malarial and anti-haemozoin activity had a good correlation for quinolines for sensitive strains (R<jats:sup>2<\/jats:sup> ranging from 0.66 to 0.95) and xanthones (Spearman \u03c1\u2009=\u20090.886). However, these correlations were reached after removing some compounds which had non-detectable anti-malarial or anti-haemozoin effects. Other structures (acridines, pyrolidines) showed negligible correlation with Spearman \u03c1 ranging from 0.095 to 0.381 for acridines, and r varying from 0.54 to 0.62 for pyrolidines. Some good correlations were only shown in a logarithmic manner or when the anti-malarial activity was normalized.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>The results raised a relative relationship between anti-haemozoin and in vitro anti-malarial activities. Some studies reported compounds that were effective in the inhibition of haemozoin formation, but failed to inhibit the parasite survival and vice versa. The correlation results in these studies were calculated after these compounds were removed from their analysis. The ability of anti-malarial compounds to accumulate inside the reaction site might strengthen their anti-malarial activity.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12936-020-03370-x","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T12:58:18Z","timestamp":1598878698000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Correlation between anti-malarial and anti-haemozoin activities of anti-malarial compounds"],"prefix":"10.1186","volume":"19","author":[{"given":"Dao Ngoc Hien","family":"Tam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gehad Mohamed","family":"Tawfik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr Ehab","family":"El-Qushayri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghaleb Muhammad","family":"Mehyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedralmontaha","family":"Istanbuly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedighe","family":"Karimzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vo Linh","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Truong","family":"Van Dat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuong Thuy Viet","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9543-9440","authenticated-orcid":false,"given":"Nguyen Tien","family":"Huy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,21]]},"reference":[{"key":"3370_CR1","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.2217\/fmb.10.136","volume":"5","author":"IB M\u00fcller","year":"2010","unstructured":"M\u00fcller IB, Hyde JE. Antimalarial drugs: modes of action and mechanisms of parasite resistance. Future Microbiol. 2010;5:1857\u201373.","journal-title":"Future Microbiol"},{"key":"3370_CR2","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1086\/652240","volume":"201","author":"CJ Sutherland","year":"2010","unstructured":"Sutherland CJ, Tanomsing N, Nolder D, Oguike M, Jennison C, Pukrittayakamee S, et al. Two nonrecombining sympatric forms of the human malaria parasite Plasmodium ovale occur globally. J Infect Dis. 2010;201:1544\u201350.","journal-title":"J Infect Dis"},{"key":"3370_CR3","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2174\/138955709787316074","volume":"9","author":"S Turschner","year":"2009","unstructured":"Turschner S, Efferth T. Drug resistance in Plasmodium: natural products in the fight against malaria. Mini Rev Med Chem. 2009;9:206\u201314.","journal-title":"Mini Rev Med Chem"},{"key":"3370_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4269\/ajtmh.2004.71.167","volume":"71","author":"FP Mockenhaupt","year":"2004","unstructured":"Mockenhaupt FP, Ehrhardt S, Burkhardt J, Bosomtwe SY, Laryea S, Anemana SD, et al. Manifestation and outcome of severe malaria in children in northern Ghana. Am J Trop Med Hyg. 2004;71:167\u201372.","journal-title":"Am J Trop Med Hyg"},{"key":"3370_CR5","first-page":"115","volume":"42","author":"AR Parhizgar","year":"2017","unstructured":"Parhizgar AR, Tahghighi A. Introducing new antimalarial analogues of chloroquine and amodiaquine: a narrative review. Iran J Med Sci. 2017;42:115\u201328.","journal-title":"Iran J Med Sci"},{"key":"3370_CR6","doi-asserted-by":"publisher","first-page":"e309","DOI":"10.1371\/journal.pmed.0040309","volume":"4","author":"A Bhattarai","year":"2007","unstructured":"Bhattarai A, Ali AS, Kachur SP, M\u00e5rtensson A, Abbas AK, Khatib R, et al. Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. PLoS Med. 2007;4:e309.","journal-title":"PLoS Med"},{"key":"3370_CR7","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411\u201323.","journal-title":"N Engl J Med"},{"key":"3370_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.freeradbiomed.2012.04.028","volume":"53","author":"M Goyal","year":"2012","unstructured":"Goyal M, Singh P, Alam A, Das SK, Iqbal MS, Dey S, et al. Aryl aryl methyl thio arenes prevent multidrug-resistant malaria in mouse by promoting oxidative stress in parasites. Free Radic Biol Med. 2012;53:129\u201342.","journal-title":"Free Radic Biol Med"},{"key":"3370_CR9","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1098\/rstb.2011.0091","volume":"366","author":"AV Hill","year":"2011","unstructured":"Hill AV. Vaccines against malaria. Philos Trans R Soc Lond B Biol Sci. 2011;366:2806\u201314.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"3370_CR10","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1017\/S1462399409001318","volume":"11","author":"R Wang","year":"2009","unstructured":"Wang R, Smith JD, Kappe SH. Advances and challenges in malaria vaccine development. Expert Rev Mol Med. 2009;11:e39.","journal-title":"Expert Rev Mol Med"},{"key":"3370_CR11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1586\/ecp.09.28","volume":"2","author":"A Alam","year":"2009","unstructured":"Alam A, Goyal M, Iqbal MS, Pal C, Dey S, Bindu S, et al. Novel antimalarial drug targets: hope for new antimalarial drugs. Expert Rev Clin Pharmacol. 2009;2:469\u201389.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"3370_CR12","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1172\/JCI21682","volume":"113","author":"NJ White","year":"2004","unstructured":"White NJ. Antimalarial drug resistance. J Clin Invest. 2004;113:1084.","journal-title":"J Clin Invest"},{"key":"3370_CR13","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/cmdc.201500349","volume":"10","author":"L Jacobs","year":"2015","unstructured":"Jacobs L, de Kock C, de Villiers KA, Smith PJ, Smith VJ, van Otterlo WA, et al. Design, synthesis, and evaluation of novel ferroquine and phenylequine analogues as potential antiplasmodial agents. ChemMedChem. 2015;10:2099\u2013110.","journal-title":"ChemMedChem"},{"key":"3370_CR14","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1126\/science.1155165","volume":"320","author":"NJ White","year":"2008","unstructured":"White NJ. Qinghaosu (artemisinin): the price of success. Science. 2008;320:330\u20134.","journal-title":"Science"},{"key":"3370_CR15","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1177\/153537020222600806","volume":"226","author":"AU Orjih","year":"2001","unstructured":"Orjih AU. On the mechanism of hemozoin production in malaria parasites: activated erythrocyte membranes promote \u03b2-hematin synthesis. Exp Biol Med. 2001;226:746\u201352.","journal-title":"Exp Biol Med"},{"key":"3370_CR16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1073\/pnas.22.4.210","volume":"22","author":"L Pauling","year":"1936","unstructured":"Pauling L, Coryell CD. The magnetic properties and structure of hemoglobin, oxyhemoglobin and carbonmonoxyhemoglobin. Proc Natl Acad Sci USA. 1936;22:210\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3370_CR17","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1073\/pnas.74.7.2612","volume":"74","author":"L Pauling","year":"1977","unstructured":"Pauling L. Magnetic properties and structure of oxyhemoglobin. Proc Natl Acad Sci USA. 1977;74:2612\u20133.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3370_CR18","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.lfs.2006.11.008","volume":"80","author":"S Kumar","year":"2007","unstructured":"Kumar S, Guha M, Choubey V, Maity P, Bandyopadhyay U. Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update. Life Sci. 2007;80:813\u201328.","journal-title":"Life Sci"},{"key":"3370_CR19","doi-asserted-by":"publisher","first-page":"e6957-e","DOI":"10.1371\/journal.pone.0006957","volume":"4","author":"M Jaramillo","year":"2009","unstructured":"Jaramillo M, Bellemare M-J, Martel C, Shio MT, Contreras AP, Godbout M, et al. Synthetic Plasmodium-like hemozoin activates the immune response: a morphology\u2014function study. PLoS ONE. 2009;4:e6957-e.","journal-title":"PLoS ONE"},{"key":"3370_CR20","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1128\/AAC.00985-06","volume":"51","author":"NT Huy","year":"2007","unstructured":"Huy NT, Uyen DT, Maeda A, Trang DTX, Oida T, Harada S, et al. Simple colorimetric inhibition assay of heme crystallization for high-throughput screening of antimalarial compounds. Antimicrob Agents Chemother. 2007;51:350\u20133.","journal-title":"Antimicrob Agents Chemother"},{"key":"3370_CR21","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.ejmech.2009.10.023","volume":"45","author":"BN Acharya","year":"2010","unstructured":"Acharya BN, Saraswat D, Tiwari M, Shrivastava AK, Ghorpade R, Bapna S, et al. Synthesis and antimalarial evaluation of 1, 3, 5-trisubstituted pyrazolines. Eur J Med Chem. 2010;45:430\u20138.","journal-title":"Eur J Med Chem"},{"key":"3370_CR22","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1021\/ml4001084","volume":"4","author":"WA Andayi","year":"2013","unstructured":"Andayi WA, Egan TJ, Gut J, Rosenthal PJ, Chibale K. Synthesis, antiplasmodial activity, and \u03b2-hematin inhibition of hydroxypyridone\u2013chloroquine hybrids. ACS Med Chem Lett. 2013;4:642\u20136.","journal-title":"ACS Med Chem Lett"},{"key":"3370_CR23","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1128\/AAC.42.3.682","volume":"42","author":"SR Hawley","year":"1998","unstructured":"Hawley SR, Bray PG, Mungthin M, Atkinson JD, O\u2019Neill PM, Ward SA. Relationship between antimalarial drug activity, accumulation, and inhibition of heme polymerization in Plasmodium falciparum in vitro. Antimicrob Agents Chemother. 1998;42:682\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"3370_CR24","doi-asserted-by":"publisher","first-page":"8032","DOI":"10.1016\/j.bmc.2009.10.005","volume":"17","author":"L Guetzoyan","year":"2009","unstructured":"Guetzoyan L, Yu X-M, Ramiandrasoa F, Pethe S, Rogier C, Pradines B, et al. Antimalarial acridines: synthesis, in vitro activity against P. falciparum and interaction with hematin. Bioorg Med Chem. 2009;17:8032\u20139.","journal-title":"Bioorg Med Chem"},{"key":"3370_CR25","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1016\/j.ejmech.2008.02.005","volume":"43","author":"BN Acharya","year":"2008","unstructured":"Acharya BN, Saraswat D, Kaushik MP. Pharmacophore based discovery of potential antimalarial agent targeting haem detoxification pathway. Eur J Med Chem. 2008;43:2840\u201352.","journal-title":"Eur J Med Chem"},{"key":"3370_CR26","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1016\/j.lfs.2003.10.003","volume":"74","author":"CD Fitch","year":"2004","unstructured":"Fitch CD. Ferriprotoporphyrin IX, phospholipids, and the antimalarial actions of quinoline drugs. Life Sci. 2004;74:1957\u201372.","journal-title":"Life Sci"},{"key":"3370_CR27","doi-asserted-by":"publisher","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","volume":"6","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6:e1000100.","journal-title":"PLoS Med"},{"key":"3370_CR28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s41182-019-0165-6","volume":"47","author":"GM Tawfik","year":"2019","unstructured":"Tawfik GM, Dila KAS, Mohamed MYF, Tam DNH, Kien ND, Ahmed AM, et al. A step by step guide for conducting a systematic review and meta-analysis with simulation data. Trop Med Health. 2019;47:46.","journal-title":"Trop Med Health"},{"key":"3370_CR29","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.toxlet.2009.05.013","volume":"189","author":"K Schneider","year":"2009","unstructured":"Schneider K, Schwarz M, Burkholder I, Kopp-Schneider A, Edler L, Kinsner-Ovaskainen A, et al. \u201cToxRTool\u201d, a new tool to assess the reliability of toxicological data. Toxicol Lett. 2009;189:138\u201344.","journal-title":"Toxicol Lett"},{"key":"3370_CR30","doi-asserted-by":"publisher","first-page":"6477","DOI":"10.1021\/jm1006484","volume":"53","author":"SJ Burgess","year":"2010","unstructured":"Burgess SJ, Kelly JX, Shomloo S, Wittlin S, Brun R, Liebmann K, et al. Synthesis, structure\u2013activity relationship, and mode-of-action studies of antimalarial reversed chloroquine compounds. J Med Chem. 2010;53:6477\u201389.","journal-title":"J Med Chem"},{"key":"3370_CR31","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0006-2952(97)00510-8","volume":"55","author":"A Dorn","year":"1998","unstructured":"Dorn A, Vippagunta SR, Matile H, Jaquet C, Vennerstrom JL, Ridley RG. An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials. Biochem Pharmacol. 1998;55:727\u201336.","journal-title":"Biochem Pharmacol"},{"key":"3370_CR32","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1021\/jm020858u","volume":"45","author":"CH Kaschula","year":"2002","unstructured":"Kaschula CH, Egan TJ, Hunter R, Basilico N, Parapini S, Taramelli D, et al. Structure\u2013activity relationships in 4-aminoquinoline antiplasmodials. The role of the group at the 7-position. J Med Chem. 2002;45:3531\u20139.","journal-title":"J Med Chem"},{"key":"3370_CR33","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ijpddr.2014.08.002","volume":"4","author":"RD Sandlin","year":"2014","unstructured":"Sandlin RD, Fong KY, Wicht KJ, Carrell HM, Egan TJ, Wright DW. Identification of \u03b2-hematin inhibitors in a high-throughput screening effort reveals scaffolds with in vitro antimalarial activity. Int J Parasitol Drugs Drug Resist. 2014;4:316\u201325.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"3370_CR34","doi-asserted-by":"publisher","first-page":"4360","DOI":"10.1021\/jm9803828","volume":"41","author":"JL Vennerstrom","year":"1998","unstructured":"Vennerstrom JL, Ager AL, Dorn A, Andersen SL, Gerena L, Ridley RG, et al. Bisquinolines. 2. Antimalarial N, N-bis (7-chloroquinolin-4-yl) heteroalkanediamines. J Med Chem. 1998;41:4360\u20134.","journal-title":"J Med Chem"},{"key":"3370_CR35","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0014-5793(97)00405-5","volume":"409","author":"MV Ignatushchenko","year":"1997","unstructured":"Ignatushchenko MV, Winter R, B\u00e4chinger HP, Hinrichs DJ, Riscoe MK. Xanthones as antimalarial agents; studies of a possible mode of action. FEBS Lett. 1997;409:67\u201373.","journal-title":"FEBS Lett"},{"key":"3370_CR36","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1016\/j.bbagen.2014.02.009","volume":"1840","author":"LM Coronado","year":"2014","unstructured":"Coronado LM, Nadovich CT, Spadafora C. Malarial hemozoin: from target to tool. Biochim Biophys Acta. 2014;1840:2032\u201341.","journal-title":"Biochim Biophys Acta"},{"key":"3370_CR37","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.4155\/fmc.13.113","volume":"5","author":"KY Fong","year":"2013","unstructured":"Fong KY, Wright DW. Hemozoin and antimalarial drug discovery. Future Med Chem. 2013;5:1437\u201350.","journal-title":"Future Med Chem"},{"key":"3370_CR38","doi-asserted-by":"publisher","first-page":"14552","DOI":"10.1038\/srep14552","volume":"5","author":"S Pulcini","year":"2015","unstructured":"Pulcini S, Staines HM, Lee AH, Shafik SH, Bouyer G, Moore CM, et al. Mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, enlarge the parasite\u2019s food vacuole and alter drug sensitivities. Sci Rep. 2015;5:14552.","journal-title":"Sci Rep"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-020-03370-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-020-03370-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-020-03370-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T23:18:47Z","timestamp":1629501527000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-020-03370-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,21]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3370"],"URL":"https:\/\/doi.org\/10.1186\/s12936-020-03370-x","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,21]]},"assertion":[{"value":"27 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"298"}}